PARVAXOR 40mg/5mg capsules EGIS
atorvastatin + perindopril Indicated for: dyslipidemia; hypertension
letter P · page 18
atorvastatin + perindopril Indicated for: dyslipidemia; hypertension
ascorbic acid Indicated for: vitamin deficiency
aflibercept Indicated for: macular degeneration; diabetic macular edema
S01LA05 Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents
aflibercept Indicated for: macular degeneration; diabetic macular edema
S01LA05 Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents
fluticasone propionate Indicated for: asthma; chronic obstructive pulmonary disease
salmeterol + fluticasone Indicated for: asthma; chronic obstructive pulmonary disease
salmeterol + fluticasone Indicated for: asthma; chronic obstructive pulmonary disease
salmeterol + fluticasone Indicated for: asthma; chronic obstructive pulmonary disease
pancuronium bromide Indicated for: muscle relaxation in anesthesia
oxeladine Indicated for: dry cough
oxeladine Indicated for: dry cough
oxeladine Indicated for: dry cough
paclitaxel Indicated for: cancer
paroxetine Indicated for: depression; anxiety disorders
N06AB05 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
nirmatrelvir + ritonavir Indicated for: COVID-19
J05AE30 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
paclitaxel Indicated for: cancer
pazopanib Indicated for: cancer
pazopanib Indicated for: cancer
pazopanib Indicated for: cancer
pazopanib Indicated for: cancer